AKR1C3 and Familial prostate cancer: Contradictory to this hypothesis, i.e., that high expression of AKR1C3 is protective against androgen load, is a study by Stanbrough et al. (2006) who found a 5.2-fold increase of AKR1C3 mRNA level in androgen-independent prostate cancer bone metastasis.